Researchers identify signatures that predict how a person will respond to an immune system stimulus.

Researchers find key drivers of allograft rejection!

A tumor metabolome panel identifies altered cell states that lead to drug tolerance.

Discover how scientists use multi-omic approaches to identify functional changes that lead to cancer cell drug resistance and devise new treatment strategies.

Single-cell proteomics provides novel insights to COVID-19 disease progression

Explore just how indispensible mass spectrometry is becoming to life science researchers.

Download this research summary to learn about how single-cell proteomics and metabolomics methods unlock drug resistance mechanisms!

James R. Heath, PhD, President of the Institute for Systems Biology will discuss key single-cell learnings and applications from the large Seattle-based academic pharmaceutical consortium committed to defining molecular mechanisms of SARS-CoV-2 infection and identifying potential prognostic immune biomarkers. Stacey Willard, PhD, from IsoPlexis will discuss how functional phenotyping individual immune cells using IsoPlexis technology edges researchers closer to predicting the risk for severe disease. 

What does it take to understand cancer? And how do you probe the molecular landscape of your experimental model?